COPD improved with cholesterol lowering agent

A hypolipidemic agent, or statin, prescribed to people with high cholesterol has been shown to reduce inflammation in lung disease cause by smoking. This property decreases the degree of destruction to the lung that occurs in chronic obstructive pulmonary disease (COPD) and also reduces the formation of cholesterol deposits in the blood vessels, promoting increased blood supply to damaged tissue.

Source: summary of medical news story as reported by Reuters

Related Disease Topics:

• High cholesterol
• Lung disease
• Chronic obstructive pulmonary disease
• COPD

Article Source Details

About: COPD improved with cholesterol lowering agent

Date: 1 November 2005

Source: Reuters

URL: http://msnbc.msn.com/id/9883791/

Related Medical Topics

This summary article refers to the following medical categories:

• Cause of COPD
• Cause of lung disease
• Cause of chronic obstructive pulmonary disease
• Medication
• Medication and cholesterol lowering agents
• Medication and lipid lowering agents
• Medication and hypolipidemics
• Medication and hypolipidemic agents
• Medication and statin
• Medication and high cholesterol
• Medication and lung disease
• Medication and chronic obstructive pulmonary disease
• Medication and COPD
• Research
• Research and cholesterol lowering agents
• Research and lipid lowering agents
• Research and hypolipidemics
• Research and hypolipidemic agents
• Research and statin
• Research and high cholesterol
• Research and lung disease
• Research and chronic obstructive pulmonary disease
• Research and COPD

More News Topics

Search Specialists by State and City